Regulatory Reform Outcomes and Accelerated Regulatory Pathways for New Prescription Medicines in Australia

National Regulatory Authorities (NRAs) globally are facing the challenge of evaluating pharmaceutical products in a speedy manner, whilst simultaneously ensuring adequate efficacy, safety and quality of approved products. Additionally, common expectations include that the evaluation process is compe...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoffe, Alina, Liu, Johnson, Smith, Greg, Chisholm, Orin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589776/
https://www.ncbi.nlm.nih.gov/pubmed/36271207
http://dx.doi.org/10.1007/s43441-022-00465-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589776/
https://www.ncbi.nlm.nih.gov/pubmed/36271207
http://dx.doi.org/10.1007/s43441-022-00465-2

Ejemplares similares